Gilead Sciences Inc/ US3755581036 /
14/11/2024 18:08:50 | Chg. -0.3050 | Volume | Bid18:08:51 | Ask18:08:51 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
92.3250USD | -0.33% | 2.42 mill. Turnover: 161.47 mill. |
92.3200Bid Size: 300 | 92.3300Ask Size: 600 | 115.22 bill.USD | 3.25% | 20.36 |
Assets
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 2,865 | 3,295 | 4,006 | 4,502 | 4,967 | ||||||
Intangible Assets | 8,971 | 17,100 | 15,738 | 13,786 | 33,126 | ||||||
Long-Term Investments | 20,485 | 11,184 | 1,423 | 1,488 | 502 | ||||||
Fixed Assets | 36,532 | 38,460 | 27,839 | 31,331 | 52,411 | ||||||
Inventories | 1,587 | 801 | 814 | 922 | 1,683 | ||||||
Accounts Receivable | 4,514 | 3,851 | 3,327 | 3,582 | 4,892 | ||||||
Cash and Cash Equivalents | 8,229 | 7,588 | 17,940 | 11,631 | 5,997 | ||||||
Current Assets | 20,445 | 31,823 | 35,836 | 30,296 | 15,996 | ||||||
Total Assets | 56,977 | 70,283 | 63,675 | 61,627 | 68,407 |
Liabilities
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1,206 | 814 | 790 | 713 | 844 | ||||||
Long-term debt | 26,346 | 30,795 | 24,574 | 22,094 | 28,645 | ||||||
Liabilities to Banks | - | - | - | - | - | ||||||
Provisions | - | - | - | - | - | ||||||
Liabilities | 37,614 | 49,782 | 42,141 | 38,977 | 50,186 | ||||||
Share Capital | 1 | 1 | 1 | 1 | 1 | ||||||
Total Equity | 19,363 | 20,501 | 21,534 | 22,650 | 18,221 | ||||||
Minority Interests | 476 | 59 | 147 | 125 | 19 | ||||||
Total liabilities equity | 56,977 | 70,283 | 63,675 | 61,627 | 68,407 |
Income Statement
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 30,390 | 26,107 | 22,127 | 22,449 | 24,689 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | 17,633 | 14,124 | 8,200 | 4,287 | 4,071 | ||||||
Interest Income | -964 | -1,118 | -1,077 | -995 | -984 | ||||||
Income Before Taxes | 17,097 | 13,529 | 7,799 | 5,160 | 1,669 | ||||||
Income Taxes | 3,609 | 8,885 | 2,339 | -204 | 1,580 | ||||||
Minority Interests Profit | -13 | 16 | 5 | -22 | -34 | ||||||
Net Income | 13,501 | 4,628 | 5,455 | 5,386 | 123 |
Per Share
Cash Flow
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 16,669 | 11,898 | 8,400 | 9,144 | 8,168 | ||||||
Cash Flow from Investing Activities | -11,985 | -16,069 | 14,355 | -7,817 | -14,615 | ||||||
Cash Flow from Financing | -9,347 | 3,393 | -12,318 | -7,634 | 770 | ||||||
Decrease / Increase in Cash | -4,622 | -641 | 10,352 | -6,309 | -5,634 | ||||||
Employees | 9,000 | 10,000 | 11,000 | 11,800 | 13,600 |